RIGL

Rigel Pharmaceuticals Inc

A South San Francisco biotechnology company that develops and sells prescription medicines for blood disorders and cancer. Its FDA-approved drugs include Tavalisse for immune thrombocytopenia (a low blood-platelet condition) and Rezlidhia for a form of acute myeloid leukemia. Founded in 1996, the company shares its name with Rigel, a brilliant blue star in the Orion constellation whose Arabic name means "the foot of the giant."

Recent Activity

Show $

2021Q2

1 sell

Maverick CapitalEXIT

-151.1K shares

Maverick CapitalEXIT

-151.1K shares

2021Q1

1 buy

Maverick CapitalNEW

+151.1K shares

Maverick CapitalNEW

+151.1K shares